v3.26.1
Benefit Plans (Tables)
 12 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Performance Shares, Activity
The Performance Share performance targets were set forth below.

Trailing 4-Quarter EPS Targets for
September 30, 2018 through March 31, 2025		Restricted Stock Eligible for Vesting
(Percentage of Award)
$16.3540%
$20.4560%
The 2025 Performance Shares performance target is set forth below.

Trailing 4-Quarter EPS Targets for
July 1, 2025 through March 31, 2027		Restricted Stock Eligible for Vesting
(Percentage of Award)
$18.40100%
Schedule of Weighted-Average Assumptions This fair value was estimated at grant date using the weighted-average assumptions listed below.
 202620252024
Dividend yield— %— %— %
Expected volatility55.37 %59.50 %62.55 %
Average risk-free interest rate3.60 %4.38 %4.69 %
Expected life4.4 years4.5 years4.6 years
Schedule of Stock Option Activity
Option activity for the year ended March 31, 2026 was as follows:
 SharesWeighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual Term		Aggregate
Intrinsic
Value
Options outstanding, beginning of year169,154 $111.55   
Granted416 179.28   
Exercised(26,609)102.89   
Forfeited(7,218)111.78   
Expired(934)189.45   
Options outstanding, end of period134,809  4$112.92 4.68$3,637,710 
Options exercisable, end of period112,772 $112.63 3.90$3,155,485 
Schedule of Intrinsic Value of Options Exercised The total intrinsic value and tax benefit of options exercised during the years ended March 31, 2026, 2025, and 2024 were as follows:
202620252024
Intrinsic value of options exercised$1,551,760$961,758$1,556,871
Tax benefit of options exercised$380,181$235,631$381,433
Schedule of the Status and Changes Restricted Stock
A summary of the status of the Company’s restricted stock as of March 31, 2026 and changes during the year ended March 31, 2026, are presented below:
 SharesWeighted Average Fair
Value at Grant Date
Outstanding at March 31, 2025159,683 $105.52 
Granted during the period183,500 156.72 
Vested during the period(166,652)107.99 
Forfeited during the period(4,031)145.99 
Outstanding at March 31, 2026172,500 $156.65 
Schedule of Share-based Compensation Included as a Component of Net Income
Total stock-based compensation included as a component of personnel expenses in the Company's Consolidated Statements of Operations during the years ended March 31, 2026, 2025, and 2024 was as follows:
 202620252024
Stock-based compensation related to equity classified units: 
Stock-based compensation (reversal) related to stock options$1,017,145 $607,275 $(3,754,209)
Stock-based compensation (reversal) related to restricted stock18,325,357 (20,296,243)2,071,122 
Total stock-based compensation related to equity classified awards$19,342,502 $(19,688,968)$(1,683,087)